| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| COCP | Cocrystal Pharma, Inc. | Fred Hassan | Director | Oct 28, 2025 | Award/Grant | $1.39 | 359,713 | 500,001 | 1,383,009 | Oct 30, 2025, 04:15 PM | |
| PGEN | PRECIGEN, INC. | Fred Hassan | Director | Mar 14, 2025 | Option/RSU Exercise | - | 87,412 | - | 1,153,452 | Mar 17, 2025, 06:33 PM | |
| PGEN | PRECIGEN, INC. | Fred Hassan | Director | Mar 13, 2025 | Award/Grant | $1.74 | 36,206 | 62,998 | 1,066,040 | Mar 17, 2025, 06:33 PM | |
| PGEN | PRECIGEN, INC. | Fred Hassan | Director | Mar 14, 2024 | Award/Grant | $1.43 | 44,055 | 62,999 | 1,029,834 | Mar 18, 2024, 06:20 PM | |
| PGEN | PRECIGEN, INC. | Fred Hassan | Director | Mar 09, 2024 | Option/RSU Exercise | - | 106,837 | - | 985,779 | Mar 12, 2024, 07:53 PM | |
| PGEN | PRECIGEN, INC. | Fred Hassan | Director | Aug 14, 2023 | Buy | $1.75 | 570,345 | 998,104 | 878,942 | Aug 16, 2023, 04:31 PM | |
| PGEN | PRECIGEN, INC. | Fred Hassan | Director | Mar 09, 2023 | Award/Grant | $1.17 | 48,290 | 56,499 | 308,597 | Mar 13, 2023, 05:02 PM | |
| PGEN | PRECIGEN, INC. | Fred Hassan | Director | Feb 22, 2023 | Option/RSU Exercise | - | 61,576 | - | 260,307 | Feb 24, 2023, 08:09 PM | |
| PGEN | PRECIGEN, INC. | Fred Hassan | Director | Mar 25, 2022 | Option/RSU Exercise | - | 16,212 | - | 198,731 | Mar 29, 2022, 05:04 PM | |
| PGEN | PRECIGEN, INC. | Fred Hassan | Director | Feb 22, 2022 | Award/Grant | $2.03 | 27,832 | 56,499 | 182,519 | Feb 24, 2022, 05:48 PM | |
| BBIO | BridgeBio Pharma, Inc. | Fred Hassan | Director | Dec 29, 2021 | Buy | $14.17 | 19,300 | 273,390 | 19,300 | Jan 03, 2022, 07:50 PM | |
| PGEN | PRECIGEN, INC. | Fred Hassan | Director | Mar 25, 2021 | Award/Grant | $7.71 | 7,328 | 56,499 | 154,687 | Mar 29, 2021, 07:46 PM | |
| PGEN | PRECIGEN, INC. | Fred Hassan | Director | Mar 13, 2021 | Option/RSU Exercise | - | 62,189 | - | 147,359 | Mar 16, 2021, 04:35 PM | |
| PGEN | PRECIGEN, INC. | Fred Hassan | Director | Mar 13, 2020 | Award/Grant | $2.01 | 28,109 | 56,499 | 85,170 | Mar 17, 2020, 06:32 PM | |
| PGEN | PRECIGEN, INC. | Fred Hassan | Director | Mar 08, 2020 | Option/RSU Exercise | - | 24,703 | - | 57,061 | Mar 10, 2020, 04:18 PM | |
| XON | INTREXON CORP | Fred Hassan | Director | Mar 23, 2019 | Option/RSU Exercise | - | 7,911 | - | 32,358 | Mar 26, 2019, 05:49 PM | |
| XON | INTREXON CORP | Fred Hassan | Director | Mar 08, 2019 | Award/Grant | $5.06 | 11,166 | 56,500 | 24,447 | Mar 18, 2019, 05:25 PM | |
| XON | INTREXON CORP | Fred Hassan | Director | Mar 23, 2018 | Award/Grant | $15.80 | 3,575 | 56,485 | 13,281 | Mar 29, 2018, 05:54 PM | |
| XON | INTREXON CORP | Fred Hassan | Director | Dec 01, 2016 | Buy | $29.02 | 6,900 | 200,266 | 6,900 | Dec 05, 2016, 11:14 AM | |
| AMGN | AMGEN INC | Fred Hassan | Director | Aug 19, 2015 | Buy | $166.63 | 3,010 | 501,563 | 3,582 | Aug 20, 2015, 05:58 PM | |
| VRX | Valeant Pharmaceuticals International, Inc. | Fred Hassan | Director | Aug 29, 2013 | Buy | $99.01 | 51,000 | 5,049,459 | 53,969 | Sep 03, 2013, 05:17 PM |